Jeffrey S. Hackman - 15 Aug 2024 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role
Chief Executive Officer, Director
Signature
/s/ Jeffrey Hackman
Issuer symbol
FENC
Transactions as of
15 Aug 2024
Net transactions value
+$2,232,000
Form type
4
Filing time
19 Aug 2024, 18:59:29 UTC
Previous filing
28 Sep 2023
Next filing
03 Apr 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FENC Stock Options Award $2,232,000 +400,000 $5.58 400,000 15 Aug 2024 Common Shares 400,000 $5.58 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On August 15, 2024, Jeffrey Hackman was granted incentive stock options to purchase 400,000 shares of the issuers common shares pursuant to the Issuer's 2020 Equity Incentive Plan.
F2 One-third of the shares subject to this option may be exercised as of August 5, 2025 ("Vesting Commencement Date"). One twenty-fourth of the shares subject to this option shall vest and may be exercised as of the last day of each month following the Vesting Commencement Date. As of August 5, 2027, 100% of the total number of shares subject to this option shall be vested.